These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3501710)

  • 1. Cytosine arabinoside in the treatment of T-cell acute lymphoblastic leukemia.
    Wiley JS; Woodruff RK; Jamieson GP; Firkin FC; Sawyer WH
    Aust N Z J Med; 1987 Aug; 17(4):379-86. PubMed ID: 3501710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.
    Wiley JS; Taupin J; Jamieson GP; Snook M; Sawyer WH; Finch LR
    J Clin Invest; 1985 Feb; 75(2):632-42. PubMed ID: 3871794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytosine arabinoside influx and nucleoside transport sites in acute leukemia.
    Wiley JS; Jones SP; Sawyer WH; Paterson AR
    J Clin Invest; 1982 Feb; 69(2):479-89. PubMed ID: 6948829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the intracellular pharmacokinetics of cytosine arabinoside (AraC) between circulating leukemic blasts and normal mononuclear blood cells.
    Hiddemann W; Schleyer E; Unterhalt M; Zühlsdorf M; Rolf C; Reuter C; Kewer U; Uhrmeister C; Wörmann B; Büchner T
    Leukemia; 1992 Dec; 6(12):1273-80. PubMed ID: 1453772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleoside transport and cytosine arabinoside (araC) metabolism in human T lymphoblasts resistant to araC, thymidine and 6-methylmercaptopurine riboside.
    Young I; Young GJ; Wiley JS; van der Weyden MB
    Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1077-82. PubMed ID: 3877635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saturation of intracellular cytosine arabinoside triphosphate accumulation in human leukemic blast cells.
    Jamieson GP; Snook MB; Wiley JS
    Leuk Res; 1990; 14(5):475-9. PubMed ID: 2345470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing therapy for acute myeloid leukemia based on differences in intracellular metabolism of cytosine arabinoside between leukemic blasts and normal mononuclear blood cells.
    Hiddemann W; Schleyer E; Unterhalt M; Kern W; Büchner T
    Ther Drug Monit; 1996 Aug; 18(4):341-9. PubMed ID: 8857548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrogation of the prognostic significance of low leukemic cell retention of cytosine arabinoside triphosphate by intensification of therapy and by alteration in the dose and schedule of administration of cytosine arabinoside.
    Preisler HD; Rustum YM; Azarnia N; Priore R
    Cancer Chemother Pharmacol; 1987; 19(1):69-74. PubMed ID: 3815728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia--preliminary clinical and pharmacological data of a randomized comparison.
    Hiddemann W; Schleyer E; Uhrmeister C; Aul CH; Maschmeyer G; Heinecke A; Büchner T
    Cancer Treat Rev; 1990 Sep; 17(2-3):279-85. PubMed ID: 2272043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between leukemic cell retention of cytosine arabinoside triphosphate and the duration of remission in patients with acute non-lymphocytic leukemia.
    Preisler HD; Rustum Y; Priore RL
    Eur J Cancer Clin Oncol; 1985 Jan; 21(1):23-30. PubMed ID: 4038655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human leukemic myeloblasts and lymphoblasts.
    Jamieson GP; Finch LR; Snook M; Wiley JS
    Cancer Res; 1987 Jun; 47(12):3130-5. PubMed ID: 3472653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.
    Bouffard DY; Jolivet J; Leblond L; Hamelin B; Ouellet F; Barbeau S; Richard A; Gourdeau H
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):497-506. PubMed ID: 12955470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of acute leukemia cells to cytarabine is a correlate of cellular es nucleoside transporter site content measured by flow cytometry with SAENTA-fluorescein.
    Gati WP; Paterson AR; Larratt LM; Turner AR; Belch AR
    Blood; 1997 Jul; 90(1):346-53. PubMed ID: 9207471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of childhood acute lymphoblastic leukemia with intermediate-dose cytosine arabinoside and adriamycin.
    Ishii E; Hara T; Ohkubo K; Matsuzaki A; Takeuchi T; Ueda K
    Med Pediatr Oncol; 1986; 14(2):73-7. PubMed ID: 3458999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient formation of cytosine arabinoside-5'-triphosphate in leukemic blasts of human T-cell acute lymphoblastic leukemia.
    Tanaka M; Yoshida S
    Leuk Res; 1989; 13(10):931-6. PubMed ID: 2586146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport and metabolism of 1-beta-D-arabinofuranosylcytosine in human ovarian adenocarcinoma cells.
    Jamieson GP; Snook MB; Bradley TR; Bertoncello I; Wiley JS
    Cancer Res; 1989 Jan; 49(2):309-13. PubMed ID: 2910450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long intracellular retention of 4'-thio-arabinofuranosylcytosine 5'-triphosphate as a critical factor for the anti-solid tumor activity of 4'-thio-arabinofuranosylcytosine.
    Someya H; Waud WR; Parker WB
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):772-80. PubMed ID: 16180016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclopentenyl cytosine increases the phosphorylation and incorporation into DNA of 1-beta-D-arabinofuranosyl cytosine in a human T-lymphoblastic cell line.
    Verschuur AC; Van Gennip AH; Leen R; Voûte PA; Brinkman J; Van Kuilenburg AB
    Int J Cancer; 2002 Apr; 98(4):616-23. PubMed ID: 11920624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with intermediate and high dose cytosine arabinoside in refractory acute leukaemia.
    Willemze R; Fibbe WE; Zwaan FE
    Onkologie; 1983 Aug; 6(4):200-4. PubMed ID: 6355950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Induction of remission by sequential treatment with cytosine arabinoside (araC/high dose) and L-asparaginase].
    Martín-Aragonés G; Sanz MA; Martínez JA; Rafecas FJ; Gomis F; Lorenzo I; Sanz G; Marty ML
    Sangre (Barc); 1985; 30(1):15-21. PubMed ID: 3859023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.